Correlation Between Corvus Pharmaceuticals and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Arcturus Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Arcturus Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Corvus and Arcturus is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Arcturus Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 1.32 times more return on investment than Arcturus Therapeutics. However, Corvus Pharmaceuticals is 1.32 times more volatile than Arcturus Therapeutics Holdings. It trades about 0.09 of its potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.03 per unit of risk. If you would invest 71.00 in Corvus Pharmaceuticals on November 28, 2024 and sell it today you would earn a total of 342.50 from holding Corvus Pharmaceuticals or generate 482.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Arcturus Therapeutics Holdings
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Arcturus Therapeutics |
Corvus Pharmaceuticals and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Arcturus Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |